History of the CyberKnife

John Adler, MD, developed the first CyberKnife at Stanford in 1994. The CyberKnife was approved by the U.S. Food and Drug Administration in 2001.

First, the CyberKnife System uses image guidance software to track and continually adjust treatment for any patient or tumor movement. This sets it far ahead of other similar treatments. It allows patients to breathe normally and relax comfortably during treatment.

Second, some forms of radiosurgery require rigid head-frames that are screwed into the patient’s skull to minimize any movement. The CyberKnife System does not require such extreme procedures to keep patients in place, and instead relies on sophisticated tracking software, allowing for a much more comfortable and non-invasive treatment.

Third, unlike some radiosurgery systems, which can only treat tumors in the head, the CyberKnife System has unlimited reach to treat a broad range of tumors throughout the body, including the prostate, lung, brain, spine, liver, pancreas, and kidney.

And finally, the CyberKnife System’s treatment accuracy is unrivaled. Its ability to treat tumors with pin-point accuracy is unmatched by other radiation therapy and radiosurgery systems. The CyberKnife System can essentially “paint” the tumor with radiation allowing it to precisely deliver treatment to the tumor alone, sparing surrounding healthy tissue.
.

The CyberKnife System

History of the CyberKnife

International Patients



Sources: http://med.standford.edu - http://cyberknife.com